Topiramate for weight reduction in Duchenne muscular dystrophy.
Carter
Gregory T
GT
Yudkowsky
Michelle P
MP
Han
Jay J
JJ
McCrory
Megan A
MA
D000293:Adolescent; D019440:Anti-Obesity Agents / Q000008:administration & dosage*; D018687:Antidepressive Agents, Second-Generation / Q000627:therapeutic use; D001066:Appetite / Q000187:drug effects / Q000502:physiology; D001835:Body Weight / Q000187:drug effects / Q000502:physiology; D016642:Bupropion / Q000627:therapeutic use; D031204:Caloric Restriction; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005632:Fructose / Q000008:administration & dosage* / Q000031:analogs & derivatives*; D006801:Humans; D008297:Male; D020388:Muscular Dystrophy, Duchenne / Q000150:complications*; D009765:Obesity / Q000188:drug therapy* / Q000209:etiology* / Q000503:physiopathology; D000077236:Topiramate; D016896:Treatment Outcome
D019440:Anti-Obesity Agents; D018687:Antidepressive Agents, Second-Generation; D016642:Bupropion; D000077236:Topiramate; D005632:Fructose